John D. Crispino

13.6k total citations · 1 hit paper
168 papers, 8.1k citations indexed

About

John D. Crispino is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, John D. Crispino has authored 168 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 97 papers in Hematology and 68 papers in Genetics. Recurrent topics in John D. Crispino's work include Acute Myeloid Leukemia Research (74 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (43 papers) and Epigenetics and DNA Methylation (31 papers). John D. Crispino is often cited by papers focused on Acute Myeloid Leukemia Research (74 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (43 papers) and Epigenetics and DNA Methylation (31 papers). John D. Crispino collaborates with scholars based in United States, China and France. John D. Crispino's co-authors include Stuart H. Orkin, Sandeep Gurbuxani, Benjamin Goldenson, Louis C. Doré, Sébastien Malinge, Marianne E. Greene, Timothy M. Chlon, Maya Lodish, Michelle M. Le Beau and Mitchell J. Weiss and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

John D. Crispino

162 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

2002 518 citations John D. Crispino et al. profile →

Peers

Countries citing papers authored by John D. Crispino

Since Specialization

Citations

This map shows the geographic impact of John D. Crispino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Crispino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Crispino more than expected).

Fields of papers citing papers by John D. Crispino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Crispino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Crispino. The network helps show where John D. Crispino may publish in the future.

Co-authorship network of co-authors of John D. Crispino

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Crispino. A scholar is included among the top collaborators of John D. Crispino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Crispino. John D. Crispino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition 2025 ·Leukemia ·(unknown), Gerald Wertheim, Shikha Gaur, (unknown), Joseph P. Loftus, (unknown), Anil Kumar, Srividya Swaminathan, Rahul S. Bhansali, Wayne E. Childers, Huimin Geng, Thomas A. Milne, Xianxin Hua, Kathrin M. Bernt, Thierry Besson, Junwei Shi, John D. Crispino, Martin Carroll, Sarah K. Tasian, Christian Hurtz	1
2	B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation 2023 ·Nature Communications ·Liat Stoler‐Barak, Ethan Harris, Ayelet Peres, Hadas Hezroni, Mirela Kuka, Pietro Di Lucia, Amalie Grenov, Neta Gurwicz, Meital Kupervaser, Bon Ham Yip, Matteo Iannacone, Gur Yaari, John D. Crispino, Ziv Shulman	9
3	Down syndrome and leukemia: from basic mechanisms to clinical advances 2023 ·Haematologica ·André Baruchel, Jean‐Pierre Bourquin, John D. Crispino, Sergi Cuartero, Henrik Hasle, Johann Hitzler, Jan‐Henning Klusmann, Shai Izraeli, Andrew A. Lane, Sébastien Malinge, Karen R. Rabin, Irene Roberts, Sandra Ryeom, Sarah K. Tasian, Elvin Wagenblast	16
4	IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms 2022 ·Blood ·Johanna Melo‐Cardenas, (unknown), Jeremy Chase Crawford, Sandeep Gurbuxani, Anitria Cotton, (unknown), Jeffrey M. Gossett, Christian Marinaccio, Rona Singer Weinberg, Ronald Hoffman, Anna Ritá Migliaccio, Yan Zheng, Marta Derecka, Ciro R. Rinaldi, John D. Crispino	35
5	Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in Gata1low Mice 2022 ·Biomolecules ·Maria Zingariello, (unknown), (unknown), Fabrizio Martelli, Mario Falchi, (unknown), Mauro Valeri, Giuseppe Sarli, Christian Marinaccio, Johanna Melo‐Cardenas, John D. Crispino, Anna Ritá Migliaccio	8
6	Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms 2022 ·Nature Communications ·Diana Saleiro, (unknown), Ewa M. Kościuczuk, Frank Eckerdt, Elspeth M. Beauchamp, (unknown), (unknown), Mariafausta Fischietti, (unknown), (unknown), (unknown), (unknown), (unknown), Masha Kocherginsky, Rona Singer Weinberg, Eleanor N. Fish, John D. Crispino, Ronald Hoffman, Leonidas C. Platanias	15
7	Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer 2021 ·Science Advances ·(unknown), Ka-wing Fong, Jung Kim, (unknown), Xiaodong Lü, Yongik Lee, (unknown), Kristine M. Wadosky, Chunming Guo, Sarki A. Abdulkadir, John D. Crispino, Deyu Fang, Panagiotis Ntziachristos, Xin Liu, Xue Li, Yong Wan, David W. Goodrich, Jonathan C. Zhao, Jindan Yu	46
8	Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo 2019 ·Clinical Cancer Research ·Brittany A. Woods, Wei Chen, Sophia Chiu, Christian Marinaccio, Chunling Fu, (unknown), Marinka Bulic, Qiong Yang, (unknown), Shengxian Jia, Praveen Suraneni, Kailin Xu, Ross L. Levine, John D. Crispino, Qiang Wen	46
9	Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis 2019 ·Blood ·Te Ling, Yehudit Birger, Monika J. Stankiewicz, (unknown), Tomer Kalisky, Avigail Rein, (unknown), Wei Chen, Chunling Fu, Kevin Zhang, Hiral Patel, Jacek Sikora, Young Ah Goo, Neil L. Kelleher, Lihua Zou, Shai Izraeli, John D. Crispino	29
10	Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes 2018 ·Molecular Cancer Therapeutics ·Marc Payton, (unknown), (unknown), Christian Marinaccio, (unknown), Kelly Hanestad, John D. Crispino, Gloria Juan, Angela Coxon	12
11	Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis 2017 ·Leukemia ·Goar Mosoyan, T. Kraus, (unknown), Kevin H. Eng, John D. Crispino, Ronald Hoffman, Camelia Iancu‐Rubin	34
12	The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9 2016 ·Leukemia ·Joseph B. Fisher, Jonathan Peterson, Michael Reimer, Cary Stelloh, Kirthi Pulakanti, Zachary J. Gerbec, Alex Abel, (unknown), Christopher Strouse, Maureen McNulty, Subramaniam Malarkannan, John D. Crispino, Samuel Milanovich, Sridhar Rao	46
13	Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia 2013 ·Oncogene ·Eun Ji Gang, (unknown), Jennifer Pham, Yi Zhao, Nguyễn Văn Chào, (unknown), Edward Park, (unknown), Lars Klemm, Srividya Swaminathan, Edward M. Conway, Louis M. Pelus, John D. Crispino, Charles G. Mullighan, Minnie McMillan, Markus Müschen, Michaël Kahn, Yong‐Mi Kim	132
14	A Model of Early Human Embryonic Stem Cell Differentiation Reveals Inter- and Intracellular Changes on Transition to Squamous Epithelium 2011 ·Stem Cells and Development ·Vasiliy Galat, Sergey Malchenko, Yekaterina Galat, (unknown), Yuri Nikolsky, Steven T. Kosak, (unknown), Philip M. Iannaccone, John D. Crispino, Mary J.C. Hendrix	18
15	Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL 2011 ·Cancer Cell ·Raghuveer Singh Mali, Baskar Ramdas, Peilin Ma, Jianjian Shi, Veerendra Munugalavadla, Emily Sims, Lei Wei, Sasidhar Vemula, Sarah C. Nabinger, Charles B. Goodwin, Rebecca J. Chan, Fabı́ola Traina, Valeria Visconte, Ramón V. Tiu, Timothy A. Lewis, Andrew M. Stern, Qiang Wen, John D. Crispino, H. Scott Boswell, Reuben Kapur	79
16	FOG‐1‐mediated recruitment of NuRD is required for cell lineage re‐enforcement during haematopoiesis 2009 ·The EMBO Journal ·Zhiguang Gao, Zan Huang, Harold E. Olivey, Sandeep Gurbuxani, John D. Crispino, E. C. Svensson	51
17	Osteopontin Regulates Actin Cytoskeleton and Contributes to Cell Proliferation in Primary Erythroblasts 2008 ·Journal of Biological Chemistry ·(unknown), Ying Zhou, (unknown), Hui Liu, Jodie Ulaszek, (unknown), Li Zhou, Koen van Besien, John D. Crispino, Amit Verma, Philip S. Low, Amittha Wickrema	38
18	STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice 2007 ·Journal of Clinical Investigation ·Zan Huang, Terri D. Richmond, Andrew G. Muntean, Dwayne L. Barber, Mitchell J. Weiss, John D. Crispino	82
19	Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors 2001 ·Genes & Development ·John D. Crispino, Maya Lodish, Beth L. Thurberg, Silvio Litovsky, Tucker Collins, Jeffery D. Molkentin, Stuart H. Orkin	242
20	Antagonism between C/EBPβ and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors 2000 ·Genes & Development ·(unknown), Mikkel Bruhn Schuster, Holger Kulessa, John D. Crispino, Gabriele Döderlein, Stuart H. Orkin, Thomas Graf, Claus Nerlov	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact